Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$56.61 - $80.46 $1.74 Million - $2.47 Million
-30,661 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$86.23 - $125.19 $315,343 - $457,819
3,657 Added 13.54%
30,661 $2.85 Million
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $633 - $891
8 Added 0.03%
27,004 $2.42 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $722,528 - $1.19 Million
-8,821 Reduced 24.63%
26,996 $2.79 Million
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $625,555 - $1.03 Million
-11,514 Reduced 24.33%
35,817 $2.83 Million
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $477,216 - $665,046
-9,672 Reduced 16.97%
47,331 $2.74 Million
Q4 2019

Feb 14, 2020

BUY
$51.21 - $59.06 $2.92 Million - $3.37 Million
57,003 New
57,003 $3.08 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.